Open innovation, or collaborative innovation, is certainly a hot topic, and something that I’ve touched on numerous times over the past few years.
Reports have revealed that approximately 80% of organizations are engaged in some form of open innovation, with Johnson & Johnson one of the latest to try it with their JLINX platform.
JLINX is an incubator based in Belgium that offers startups a way to develop from within the companies life science ecosystem.
http://www.forbes.com/sites/adigaskell/2016/04/01/making-open-innovation-work/#42390c19489c
